Table 2.
Frequency of adverse events in this review.
| Adverse Event | Placebo Control (n = 1381) | P. Ginseng (n = 1711) |
|---|---|---|
| Dyspepsia | 13 (9.6 a , 0.9 b) | 18 (9.4 a, 1.1 b) |
| Hot flash | 19 (14.1 , 1.4) | 34 (17.8, 2.0) |
| Insomnia | 9 (6.7 , 0.7) | 20 (10.5, 1.2) |
| Constipation | 6 (4.4 , 0.4) | 10 (5.2, 0.6) |
| Low energy | 1 (0.7 , 0.1) | 4 (2.1, 0.2) |
| Headache | 10 (7.4 , 0.7) | 11 (5.8, 0.6) |
| Skin disorders | 6 (4.4 , 0.4) | 16 (8.4, 0.9) |
| Dizziness | 7 (5.2 , 0.5) | 6 (3.1, 0.4) |
| Nausea | 1 (0.7 , 0.1) | 2 (1.0, 0.1) |
| Diarrhea | 10 (7.4 , 0.7) | 12 (6.3, 0.7) |
| Abdominal pain | 0 | 2 (1.0, 0.1) |
| Nasal Bleeding | 5 (3.7 , 0.4) | 10 (5.2, 0.6) |
| Rapid heartbeat | 2 (1.5 , 0.1) | 5 (2.6, 0.3) |
| Anorexia | 6 (4.4 , 0.4) | 3 (1.6, 0.2) |
| Increased appetite | 3 (2.2 , 0.2) | 0 |
| Dried mouth | 13 (9.6 , 0.9) | 12 (6.3, 0.7) |
| Chest discomfort | 8 (5.9 , 0.6) | 9 (4.7, 0.5) |
| Eruption on the tongue | 1 (0.7, 0.1) | 0 |
| Allergy (cold allergy, systemic rash) | 0 | 3 (1.6, 0.2) |
| Common cold | 0 | 2 (1.0, 0.1) |
| Itching sensation | 2 (1.5, 0.1) | 2 (1.0, 0.1) |
| Mild fever | 1 (0.7, 0.1) | 1 (0.5, 0.1) |
| Sweating | 4 (3.0, 0.3) | 3 (1.6, 0.2) |
| Increasing blood pressure | 8 (5.9, 0.6) | 4 (2.1, 0.2) |
| Vaginal bleeding | 0 | 2 (1.0, 0.1) |
| Total events | 135 (9.8 b) | 191 (11.2 b) |
a, adverse events/total adverse events of each group × 100; b, adverse events/total participants of each group × 100.